65 I B, drugs, pharmaceuticals,&hematology related products, FSS contract award

Active Awarded Last action

Contract number
36F79720D0081
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order 96% complete
IDV ceiling
$225,000.00
Award type
Multiple award
Who can order
All agencies
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Fixed Price with Economic Price Adjustment

Award details come from SAM.gov/FPDS.

About this IDV

Acrotech Biopharma Inc. (UEI: DN63NKTYLF33) was awarded a Federal Supply Schedule contract under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule by the Veterans Integrated Service Network 12, a civilian agency within the Department of Veterans Affairs. This multiple-award contract, valued at $225,000, was established on February 15, 2020, with an ultimate completion date of February 14, 2027, representing a short-term contract extension. The contract contains no set-aside provisions and falls under General Services Administration product category 65 I B, covering drugs, pharmaceuticals, and hematology-related products. As a Federal Supply Schedule contract vehicle, this award provides the Veterans Integrated Service Network 12 with access to Acrotech Biopharma's pharmaceutical inventory and related products on pre-established pricing and terms throughout the contract period.

Under this Federal Supply Schedule arrangement, the Veterans Integrated Service Network 12 may issue task orders or place orders for pharmaceutical and hematology products as operational needs arise, with pricing and availability governed by the negotiated Federal Supply Schedule terms. The contract structure enables the VA network to procure essential medications and pharmaceutical supplies to support veteran healthcare delivery across its service region. This multiple-award vehicle provides flexibility in sourcing while maintaining cost controls through the pre-negotiated Federal Supply Schedule framework, allowing the Veterans Integrated Service Network 12 to fulfill pharmaceutical requirements efficiently without the need for individual competitive solicitations for each purchase.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00025 · Short term contract extension $0
Supplemental Agreement for work within scope P00024 · Removing six products from the FSS contract. $0
Supplemental Agreement for work within scope P00023 · 2026 public law pricing update for 14 ndcs $0
Supplemental Agreement for work within scope P00022 · Correct the NDC for one product $0
Supplemental Agreement for work within scope P00021 · Addition of one 42-2A product $0
Supplemental Agreement for work within scope P00020 · Short term contract extension $0
Supplemental Agreement for work within scope P00019 · Administrative change to update the signatory authority form. $0
Supplemental Agreement for work within scope P00018 · 2025 public law pricing update $0
Other Administrative Action P00017 · Point of contact changes $0
Supplemental Agreement for work within scope P00016 · 42-24 product deletion for 1 NDC $0
Supplemental Agreement for work within scope P00015 · 2024 public law pricing update for 15 ndcs $0
Supplemental Agreement for work within scope P00014 · FSS $0
Supplemental Agreement for work within scope P00013 · 2023 public law pricing update for 14 ndcs $0
Supplemental Agreement for work within scope P00012 · 42-2A product deletion for 2 items $0
Other Administrative Action P00011 · Administrative change to update pocs $0
Supplemental Agreement for work within scope P00010 · 2022 public law pricing update for 16 ndcs $0
Supplemental Agreement for work within scope P00009 · NDC change for 1 product $0
Other Administrative Action P00008 · Administrative correction for pricing - 2 ndcs $0
Supplemental Agreement for work within scope P00007 · 42-2A NDC change for 2 products $0
Supplemental Agreement for work within scope P00006 · Product addition for 2 ndcs $0
Other Administrative Action P00005 · Administrative change $0
Supplemental Agreement for work within scope P00004 · 2021 public law pricing update $0
Other Administrative Action P00003 $0
Supplemental Agreement for work within scope P00002 · Administrative change $0
Supplemental Agreement for work within scope P00001 · NDC change for 2 items $0
Original award $0
Show all 26

Quick answers

Who was awarded contract 36F79720D0081?

36F79720D0081 was awarded to Acrotech Biopharma Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on February 15, 2020.

How much is contract 36F79720D0081 worth?

36F79720D0081's own ceiling is $225,000.

Who can order from contract 36F79720D0081?

36F79720D0081 is a multiple award federal supply schedule. All agencies can place orders on it.

Is contract 36F79720D0081 part of a contract vehicle?

Yes. 36F79720D0081 is part of Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36F79720D0081 competed?

The extent of competition for 36F79720D0081 was full and open competition.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV